NIVEGU.KNOW BEFORE YOU FLY

THE WORLD OF AVIATION.
YOUR JOURNEY, EXPLAINED.

Search Plan my trip
NASDAQ / LIVE COMPANY INTELLIGENCE

Radiopharm Theranostics Limited

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERRADX
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / RADX COVERAGE

What’s moving Radiopharm Theranostics Limited now

Current reporting with the operating signal separated from the noise.

01
Depositary Receipt (RADX) Price Target Increased by 12.71% to 5.39

Radiopharm Theranostics Limited

The story matters when it changes Radiopharm Theranostics Limited’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Radiopharm Theranostics Limited (RADX) Investor Webinar Transcript

Radiopharm Theranostics Limited (RADX) Investor Webinar Transcript

The story matters when it changes Radiopharm Theranostics Limited’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Depositary Receipt () (RADX) with Buy Recommendation

Maxim Group Initiates Coverage of Radiopharm Theranostics Limited

The story matters when it changes Radiopharm Theranostics Limited’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

The story matters when it changes Radiopharm Theranostics Limited’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Diamond Equity Research Releases Update Note on Radiopharm Theranostics Limited (ASX: RAD)

Diamond Equity Research Releases Update Note on Radiopharm Theranostics Limited (ASX: RAD)

The story matters when it changes Radiopharm Theranostics Limited’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest RADX filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

6-KOfficial SEC filingFiled 2026-09-22 · Period 2026-09-22SEC ↗6-KOfficial SEC filingFiled 2026-09-14 · Period 2026-09-14SEC ↗424B3Official SEC filingFiled 2026-09-23SEC ↗F-3Official SEC filingFiled 2026-09-14SEC ↗6-KOfficial SEC filingFiled 2026-09-11 · Period 2026-09-11SEC ↗6-KOfficial SEC filingFiled 2026-09-09 · Period 2026-09-09SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-09-04SEC ↗SCHEDULE 13DOfficial SEC filingFiled 2026-09-04SEC ↗
EARNINGS / QUARTERLY TRACKER

Radiopharm Theranostics Limited, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.